Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Yingxue Lu
Xiaojing Ma
Jie Pan
Rongqiang Ma
Yujie Jiang
机构
[1] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Cardiology
[2] Shandong Provincial Hospital Affiliated to Shandong First Medical University,Department of Hematology
[3] Shandong Provincial Hospital Affiliated to Shandong First Medical University,undefined
关键词
Allogeneic hematopoietic stem cell transplantation; Dyslipidemia; Graft-versus-host disease; Statins; Proprotein convertase subtilisin/Kexin type 9 (PCSK9);
D O I
暂无
中图分类号
学科分类号
摘要
Dyslipidemia is one of the complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and it is often underestimated and undertreated. Dyslipidemia in allo-HSCT recipients has been confirmed to be associated with endocrine dysfunction, acute and chronic graft-versus-host disease (aGVHD and cGVHD), immunosuppressive agent application, etc. However, few studies have illustrated the accurate molecular signaling pathways involved in dyslipidemia, and there are no standard guidelines for dyslipidemia management after HSCT. This review will discuss the pathogenesis of dyslipidemia, especially the association with aGVHD and/or cGVHD. Comprehensive treatment methods for dyslipidemia after HSCT will also be summarized.
引用
收藏
相关论文
共 50 条
  • [1] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Lu, Yingxue
    Ma, Xiaojing
    Pan, Jie
    Ma, Rongqiang
    Jiang, Yujie
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
  • [2] Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management
    Griffith, Michelle L.
    Savani, Bipin N.
    Boord, Jeffrey B.
    BLOOD, 2010, 116 (08) : 1197 - 1204
  • [3] Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
    Gurman, Gunhan
    Atilla, Erden
    Ozen, Mehmet
    Kubilay, Pinar
    Yilmaz, Gulden
    Gunduz, Mehmet
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Akan, Hamdi
    Ilhan, Osman
    Beksac, Meral
    Topcuoglu, Pervin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S194 - S195
  • [4] Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: A report of the SFGM-TC on dyslipidemia and thyroid disorders
    Cornillon, J.
    Vantyghem, M. -C.
    Couturier, M. A.
    de Berranger, E.
    Francois, S.
    Hermet, E.
    Maillard, N.
    Marcais, A.
    Tabrizi, R.
    Decanter, C.
    Dulery, R.
    Bauters, F.
    Yakoub-Agha, I.
    PATHOLOGIE BIOLOGIE, 2013, 61 (04): : 168 - 170
  • [5] Erythrocytosis after allogeneic hematopoietic stem cell transplantation
    Hino, Yutaro
    Doki, Noriko
    Kurosawa, Shuhei
    Yamamoto, Keita
    Sakaguchi, Masahiro
    Harada, Kaito
    Ikegawa, Shuntaro
    Shingai, Naoki
    Hattori, Kenichiro
    Senoo, Yasushi
    Igarashi, Aiko
    Najima, Yuho
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [6] Jaundice After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendizabal, Manuel
    Chen, Terina
    Reddy, K. Rajender
    HEPATOLOGY, 2009, 50 (06) : 2044 - 2045
  • [7] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Q. Jiang
    B. H. Zhang
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 504 - 506
  • [8] Malakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation
    Robinson, Tracy
    Streu, Erin
    ONCOLOGY NURSING FORUM, 2015, 42 (05) : 558 - 561
  • [9] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Jiang, Q.
    Zhang, B. H.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (04) : 504 - 506
  • [10] Plasticity after allogeneic hematopoietic stem cell transplantation
    Rovo, Alicia
    Gratwohl, Alois
    BIOLOGICAL CHEMISTRY, 2008, 389 (07) : 825 - 836